Latest filing published 21 Aug 2024 for EyePoint, Inc., €18k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wendy F. Dicicco appears in 25 filings across five issuers: Coherent Corp. (10, Director), SWK Holdings Corp (6, Director), EyePoint, Inc. (4, Director), Renovacor, Inc. (4, Chief Financial Officer) and Akari Therapeutics PLC (1, Interim CFO). Trades run from March 30, 2016 to August 20, 2024.
The record counts 5 sales for EUR 418,395, with a median of EUR 79,138, all at Coherent Corp.: EUR 123,767 on December 23, 2016, EUR 101,778 on January 31, 2017 and EUR 79,138 on September 8, 2016. A single purchase, EUR 17,970, dated August 20, 2024 at EyePoint, Inc., makes up 17% of market trades. The rest is 10 grants, 7 option exercises and 2 filings of another kind.
Activity is concentrated in 2022 (9 filings) and 2016 (6), against just 1 in 2021. No filing falls in the last twelve months.
Francis J. Kramer and Marc Y. E. Pelaez each have 2 trades within 30 days of trades by Wendy F. Dicicco, in the same direction. Filings are published a median of 2 days after the trade.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations